Search

Your search keyword '"Zeybek, Burak"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Zeybek, Burak" Remove constraint Author: "Zeybek, Burak" Publisher elsevier bv Remove constraint Publisher: elsevier bv
22 results on '"Zeybek, Burak"'

Search Results

1. DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo

2. Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu

3. Randomized phase II trial of weekly ixabepilone with or without biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer

4. In vitro and in vivo activity of DHES0815A, an antibody-drug conjugate targeting HER2/neu in uterine serous carcinoma

6. Financial toxicity in patients with gynecologic malignancies

7. Charlson Comorbidity Index as a predictor of postoperative complication in octogenarians and nonagenarians with stage I endometrioid endometrial cancer: a single-institution retrospective review

8. Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study

9. Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma

12. In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma

14. PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib

15. PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers

16. Author's Reply

Catalog

Books, media, physical & digital resources